探索泰国社区老年人的痴呆症护理:一种定性描述性研究
Parichat Mongklam1, Phachongchit Kraithaworn1, Sangduen Piyatrakul1
1Ramathibodi School of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Belitung nursing journal
|August 6, 2025
概括
泰国的社区痴呆症护理尽管有支持性的政策,但仍面临挑战. 加强护理人员培训和综合服务对于改善护理质量和减少护理人员负担至关重要.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 痴呆症在泰国是一个越来越大的公共卫生挑战,给家庭和医疗保健系统带来了压力.
- 现有的综合护理国家政策受到资源限制,护理人员负担以及社区痴呆服务的培训机会不足的阻碍.
研究的目的:
- 探索在泰国为社区居住的老年人提供痴呆症护理.
- 从社区卫生护士 (CHN),村庄卫生志愿者 (VHV) 和家庭护理人员的角度确定护理过程,挑战和支持系统.
主要方法:
- 在泰国大都会地区,采用了定性描述方法,对22名故意选择的参与者 (CHN,VHV,家庭护理人员) 进行了研究.
- 数据收集涉及半结构面试和焦点小组讨论,并补充了健康评估.
- 主题分析利用了桑德洛夫斯基的框架,通过成员检查,审计轨道和同行汇报来确保严格.
主要成果:
- 护理过程综合了预防,促进,治疗和康复,家庭是护理的中心.
- 亲子责任和提供者社区信任的文化价值观是关键的条件因素.
- 结果包括老年人的部分独立性,但护理人员由于缺乏支持和培训而感到压力.
- 成功源于支持性的政策,家庭的奉献精神和提供者的动机.
- 障碍包括人员短缺,护理人员健康问题,有限的培训和低的VHV信心.
- 模型开发突出了政策支持,多学科合作,护理人员能力建设和专业社区服务的需要.
结论:
- 泰国的社区痴呆症护理受到文化承诺和专注的当地工作人员的影响,但受到系统性问题的限制.
- 加强护理人员教育,扩大服务网络和加强综合支持对于改善护理质量和减少护理人员负担至关重要.
- 为有效和可持续的痴呆症护理提供CHN和VHV的痴呆症专用培训,并支持他们在护理人员教育和协调方面的角色至关重要.
相关概念视频
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Documentation in Long-Term and Home Healthcare Setting
987
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
987
Cognitive Development During Adulthood
279
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
279
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Continuing Care
1.6K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669


